Recruiting The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors NCT06911710 Conditions AML (Acute Myelogenous Leukemia), B-ALL, Blood Protein Disorders, +23 more Locations TianJin China. TianJin Medical University General — Tianjin, Tianjin Municipality, China View Trial Details
Recruiting Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies NCT06909474 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +12 more Locations Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology — Wuhan, Hubei, China View Trial Details
